News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Holtzman Douglas
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/03/2023 |
4
| Holtzman Douglas (Chief Scientific Officer) has filed a Form 4 on Icosavax, Inc.
Txns:
| Sold 14,261 shares
@ $8.7413, valued at
$124.7k
Sold 2,095 shares
@ $9.5862, valued at
$20.1k
Exercised 16,356 options to buy
@ $1.04, valued at
$17k
|
|
04/05/2023 |
4
| Holtzman Douglas (Chief Scientific Officer) has filed a Form 4 on Icosavax, Inc.
Txns:
| Sold 20,143 shares
@ $6.0785, valued at
$122.4k
Sold 300 shares
@ $6.56, valued at
$2k
Exercised 20,443 options to buy
@ $1.04, valued at
$21.3k
|
|
12/16/2022 |
4
| Holtzman Douglas (Chief Scientific Officer) has filed a Form 4 on Icosavax, Inc.
Txns:
| Sold 19,648 shares
@ $11.1443, valued at
$219k
|
|
11/14/2022 |
4
| Holtzman Douglas (Chief Scientific Officer) has filed a Form 4 on Icosavax, Inc.
Txns:
| Granted 82,580 options to buy
@ $2.47, valued at
$204k
|
|
08/02/2022 |
4
| Holtzman Douglas (Chief Scientific Officer) has filed a Form 4 on Icosavax, Inc.
Txns:
| Sold 585 shares
@ $7.1076, valued at
$4.2k
Sold 9,337 shares
@ $6.6374, valued at
$62k
Sold 453 shares
@ $6.7038, valued at
$3k
Gifted 20,000 shares
@ $0 |
|
02/14/2022 |
4
| Holtzman Douglas (Chief Scientific Officer) has filed a Form 4 on Icosavax, Inc.
Txns:
| Granted 19,485 shares
@ $0 Gifted 10,000 shares
@ $0 Granted 81,950 options to buy
@ $17.55, valued at
$1.4M
|
|
08/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/28/2021 |
3
| Holtzman Douglas (Chief Scientific Officer) has filed a Form 3 on Icosavax, Inc. |
|
|